TrialThe lancet. Gastroenterology & hepatology2025

Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.

Young-Suk Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.